NEW YORK, July 19, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Bausch Health Companies Inc.:
The investigation focuses on whether Bausch Health issued false and/or misleading statements and/or failed to disclose information pertinent to investors concerning its 2022 earnings and guidance and its patent dispute over Xifaxan. On May 10, 2022, Bausch Health announced its first-quarter 2022 results, prompting the stock price to fall $3.50 per share. Analysts attributed the decline to concerns around the Company's spin-off of Bausch + Lomb Corporation, high debt levels, and anticipation over the Xifaxan patent decision. On July 28, 2022, the Company issued an update on the Xifaxan patent dispute case between Bausch Health and Norwich. In response to this news, market analysts downgraded Bausch Health and its stock price fell an additional $3.58 per share, representing a decline of more than 50% from its trading price just two months earlier.
Due to the forgoing, The Gross Law Firm is investigating potential securities fraud claims on behalf of certain Bausch Health investors. If you incurred a loss on your BHC investment, please contact us using the link below to discuss your rights.
https://securitiesclasslaw.com/securities/bausch-health-loss-submission-form/?id=42276&from=4
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content:https://www.prnewswire.com/news-releases/investigation-alert-the-gross-law-firm-notifies-shareholders-of-bausch-health-companies-inc-of-an-investigation-and-potential-class-action-lawsuit--nyse-bhc-301880307.html
SOURCE The Gross Law Firm
